Is Theravance Biopharma, Inc. technically bullish or bearish?

Nov 03 2025 11:34 AM IST
share
Share Via
As of October 31, 2025, Theravance Biopharma, Inc. shows a bullish trend supported by daily moving averages and positive indicators, despite some mixed signals from MACD and RSI, while outperforming the S&P 500 over the past year with a return of 77.91%.
As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by daily moving averages and positive signals from Bollinger Bands and KST on both weekly and monthly time frames. However, the MACD indicates a mildly bearish position on the weekly chart, and the RSI shows a bearish signal on the monthly chart. Dow Theory presents a mildly bearish view on the weekly but is mildly bullish monthly.

In terms of performance, the stock has outperformed the S&P 500 over the past year with a return of 77.91% compared to the S&P 500's 19.89%, although it has underperformed over the 3-year and 5-year periods.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News